Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Development of Fe3O4 core–TiO2 shell nanocomposites and nanoconjugates as a foundation for neuroblastoma radiosensitization

Fig. 4

Effect of MIBG nanoconjugates on neuroblastoma cell viability. a SK-N-AS cells; b SK-N-DZ; c NBL-W/S and d NBL-W/N were treated with varying concentrations of Fe3O4@TiO2–MIBG nanoconjugates. Loss of viability was observed by MTS assay as detailed. e HeLa cells treated with 100 nM or 250 nM Fe3O4@TiO2 bare nanocomposites or MIBG nanoconjugates. f SK-N-DZ cells treated with free MIBG (9.3 µM), bare nanocomposites (100 nM), or bare nanocomposites + free MIBG. No decrease in cell viability was found in either treatment condition *: < 0.05 significance level, **: < 0.01 significance level, *** < 0.001 significance level. Datapoints presented are an average of 5 biological replicates. Error bars indicate mean ± SD

Back to article page